Skip to main content
. 2013 Jul;346(1):11–22. doi: 10.1124/jpet.113.203984

Fig. 4.

Fig. 4.

Antihyperalgesic effects of intrathecal administration of BU08028, SR16435, and buprenorphine in mice with inflammatory pain. Effects of BU08028 (A), SR16435 (C), and buprenorphine (E) on paw withdrawal latencies (sec). The % maximum possible effect of BU08028 (B), SR16435 (D), and buprenorphine (F) for attenuating thermal hyperalgesia. BL, baseline values before induction of paw inflammation. Pre-, predrug values before intrathecal administration of drugs. Behavioral responses were measured at 0.5, 1, 2, 3, 4, 24, and 48 hours after drug administration. Each value represents the mean ± S.E.M. (n = 8). Symbols represent different dosing conditions in different groups of mice. *Statistically significant difference from the vehicle controls (○, 0 μg) (P < 0.05).